Medical Marijuana Inc (MJNA)
0.0021
0.00 (0.00%)
USD |
OTCM |
May 10, 14:09
Medical Marijuana Enterprise Value: 10.50M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 10.50M |
| May 08, 2024 | 9.815M |
| May 07, 2024 | 10.50M |
| May 06, 2024 | 10.50M |
| May 03, 2024 | 9.471M |
| May 02, 2024 | 9.471M |
| May 01, 2024 | 9.126M |
| April 30, 2024 | 11.88M |
| April 29, 2024 | 9.126M |
| April 26, 2024 | 9.471M |
| April 25, 2024 | 9.471M |
| April 24, 2024 | 9.643M |
| April 23, 2024 | 9.471M |
| April 22, 2024 | 9.471M |
| April 19, 2024 | 9.815M |
| April 18, 2024 | 10.85M |
| April 17, 2024 | 10.85M |
| April 16, 2024 | 11.54M |
| April 15, 2024 | 11.54M |
| April 12, 2024 | 12.57M |
| April 11, 2024 | 11.54M |
| April 10, 2024 | 12.92M |
| April 09, 2024 | 13.95M |
| April 08, 2024 | 14.29M |
| April 05, 2024 | 14.64M |
| Date | Value |
|---|---|
| April 04, 2024 | 12.57M |
| April 03, 2024 | 12.57M |
| April 02, 2024 | 12.57M |
| April 01, 2024 | 11.88M |
| March 28, 2024 | 11.54M |
| March 27, 2024 | 12.30M |
| March 26, 2024 | 11.88M |
| March 25, 2024 | 10.50M |
| March 22, 2024 | 10.16M |
| March 21, 2024 | 8.782M |
| March 20, 2024 | 10.50M |
| March 19, 2024 | 10.50M |
| March 18, 2024 | 11.54M |
| March 15, 2024 | 7.404M |
| March 14, 2024 | 7.404M |
| March 13, 2024 | 6.371M |
| March 12, 2024 | 9.126M |
| March 11, 2024 | 10.16M |
| March 08, 2024 | 10.16M |
| March 07, 2024 | 11.19M |
| March 06, 2024 | 11.19M |
| March 05, 2024 | 11.19M |
| March 04, 2024 | 11.19M |
| March 01, 2024 | 11.88M |
| February 29, 2024 | 11.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.371M
Minimum
Mar 13 2024
591.24M
Maximum
Feb 10 2021
75.49M
Average
60.81M
Median
Nov 16 2020
Enterprise Value Benchmarks
| Skye Bioscience Inc | 335.66M |
| NovaBay Pharmaceuticals Inc | 2.645M |
| Palatin Technologies Inc | 28.44M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -13.29M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8491M |
| Revenue (Quarterly) | 4.776M |
| Total Expenses (Quarterly) | 4.693M |
| Gross Profit Margin (Quarterly) | 79.95% |
| Profit Margin (Quarterly) | -17.78% |
| Earnings Yield | -4.54K% |